Skip to content

Clinical trials to evaluate clinical effectiveness and safety of Auto-suction system

Multicenter, Prospective, Comparative, Randomized, Non-inferiority, Investigator-Initiated Study to evaluate the clinical effectiveness and safety of Automatic, Closed-Suction System ‘A-1000’ in Mechanically Ventilated patients with Pneumonia (ESuction-MVP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006608
Enrollment
102
Registered
2021-09-27
Start date
2021-06-10
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Experimental group: Discharge of sputum using Auto Suction system. Control group: Discharge of sputum using regular closed suction system.

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Selection criteria 1. Adults over 19 years of age 2. Critical patients who are diagnosed with pneumonia and need mechanical ventilation 3. A person who voluntarily decided to participate in this clinical trial and agreed to the subject's explanation and consent in writing 4. A person who is willing to comply with the clinical trial plan

Exclusion criteria

Exclusion criteria: 1. A person who does not receive a bronchoscopy 2. If you are not expected to maintain mechanical ventilation for at least 3 days because you are in critical condition with an APACHE II score of 30 or higher, which is expected to be evaluated after 24 hours of initial admission for simple monitoring; 3. If the ventilator setting is FiO2>80% (intake oxygen concentration) or Plat(pressure when resting before exhalation)>30cmH2O is required to maintain high flat airway pressure 4. In the case of progressive blood cancer, failure to transplant bone marrow, granulocytosis, and severe immunodeficiency conditions such as ANC<400/mm3 5. If you have blood transfusions 6. Pregnant women or persons planning to conceive during the clinical trial period; 7. A person who has received CPR within five days of the screening date 8. Other cases where the medical staff finds it difficult to apply the medical device in consideration of the patient's condition; 9. A person who is currently participating in another clinical trial or has participated in another clinical trial within 90 days as of the screening date 10. Other cases where the tester determines that it is difficult to apply the medical device considering the patient's condition or that participation in the clinical trial is inappropriate because it may affect the results of the clinical trial.

Design outcomes

Primary

MeasureTime frame
Difference of CPIS, number of discharge of sputum, sputum CC, satisfaction of the device evaluated by medical faculty

Secondary

MeasureTime frame
Abnormal cases, incidence of complications, damage to airway mucous membranes, occurrence rate of malfunction of test equipment (assessed only by test group)

Countries

Korea, Republic of

Contacts

Public ContactHYO CHAN PARK

Seoul National University Bundang Hospital

r3092@snubh.org+82-31-787-2365

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026